Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Insights, Forecast to 2028

Q: How big is the parp poly adpribose polymerase inhibitors market?

Parp Poly AdpRibose Polymerase inhibitors is very effective in treating solid tumors and other diseases.Such as advanced ovarian cancer fallopian tube cancer and primary peritoneal cancer.Market Analysis and Insights Global PARP Poly ADPribose Polymerase Inhibitors MarketThe global PARP Poly ADPribose Polymerase Inhibitors market size is projected to reach US 21490 million by 2028 from US 2861 million in 2021 at a CAGR of 32.8 during 20222028.Fully considering the economic change by this health crisis Olaparib accounting for of the PARP Poly ADPribose Polymerase Inhibitors global mark.

Q: Who are the key players in the parp poly adpribose polymerase inhibitors market?

Some of the key players are ADP, AbbVie, Pfizer Inc, Astrazeneca plc, GlaxoSmithKline PLC, Clovis Oncology, Everest Pharmaceuticals, China, India, GlaxoSmithKline, Others.

Code: QYRE-Auto-19I2859

Report

February 2022

Pages:94

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Everest Pharmaceuticals

PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoting apoptosis of tumor cells. Parp (Poly Adp-Ribose Polymerase) inhibitors is very effective in treating solid tumors and other diseases.Such as advanced ovarian cancer, fallopian tube cancer and primary peritoneal cancer.

Market Analysis and Insights: Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market

The global PARP (Poly ADP-ribose Polymerase) Inhibitors market size is projected to reach US$ 21490 million by 2028, from US$ 2861 million in 2021, at a CAGR of 32.8% during 2022-2028.

Fully considering the economic change by this health crisis, Olaparib accounting for % of the PARP (Poly ADP-ribose Polymerase) Inhibitors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Ovarian Cancer segment is altered to an % CAGR throughout this forecast period.

China PARP (Poly ADP-ribose Polymerase) Inhibitors market size is valued at US$ million in 2021, while the North America and Europe PARP (Poly ADP-ribose Polymerase) Inhibitors are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe PARP (Poly ADP-ribose Polymerase) Inhibitors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PARP (Poly ADP-ribose Polymerase) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PARP (Poly ADP-ribose Polymerase) Inhibitors market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PARP (Poly ADP-ribose Polymerase) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PARP (Poly ADP-ribose Polymerase) Inhibitors market.

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Scope and Market Size

PARP (Poly ADP-ribose Polymerase) Inhibitors market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global PARP (Poly ADP-ribose Polymerase) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Olaparib

Talazoparib

Segment by Application

Ovarian Cancer

Breast Cancer

Other

BY COMPANY

AbbVie

Pfizer

AstraZeneca

GlaxoSmithKline

Clovis Oncology

Everest Pharmaceuticals

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Everest Pharmaceuticals

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Olaparib

1.2.3 Talazoparib

1.3 Market by Application

1.3.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Ovarian Cancer

1.3.3 Breast Cancer

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Perspective (2017-2028)

2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Trends by Region

2.2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Region (2017-2022)

2.2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2023-2028)

2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Dynamics

2.3.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Trends

2.3.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers

2.3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges

2.3.4 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue

3.1.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue (2017-2022)

3.1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Players (2017-2022)

3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue

3.4 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio

3.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2021

3.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players Head office and Area Served

3.6 Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service

3.7 Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market

3.8 Mergers & Acquisitions, Expansion Plans

4 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Type

4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Type (2017-2022)

4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2023-2028)

5 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Application

5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Application (2017-2022)

5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)

6.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

6.2.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)

6.2.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)

6.2.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)

6.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

6.3.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)

6.3.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)

6.3.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)

6.4 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country

6.4.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)

6.4.2 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)

7.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

7.2.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)

7.2.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)

7.2.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)

7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

7.3.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)

7.3.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)

7.3.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)

7.4 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country

7.4.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)

7.4.2 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)

8.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

8.2.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)

8.2.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)

8.2.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)

8.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

8.3.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)

8.3.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)

8.3.3 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)

8.4 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region

8.4.1 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2017-2022)

8.4.2 Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)

9.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

9.2.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)

9.2.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)

9.2.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)

9.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

9.3.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)

9.3.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)

9.3.3 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)

9.4 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country

9.4.1 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)

9.4.2 Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2017-2028)

10.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type

10.2.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022)

10.2.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028)

10.2.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2017-2028)

10.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application

10.3.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022)

10.3.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028)

10.3.3 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2017-2028)

10.4 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country

10.4.1 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022)

10.4.2 Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.1.4 AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

11.1.5 AbbVie Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.2.4 Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

11.2.5 Pfizer Recent Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.3.4 AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

11.3.5 AstraZeneca Recent Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.4.4 GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

11.4.5 GlaxoSmithKline Recent Developments

11.5 Clovis Oncology

11.5.1 Clovis Oncology Company Details

11.5.2 Clovis Oncology Business Overview

11.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.5.4 Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

11.5.5 Clovis Oncology Recent Developments

11.6 Everest Pharmaceuticals

11.6.1 Everest Pharmaceuticals Company Details

11.6.2 Everest Pharmaceuticals Business Overview

11.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction

11.6.4 Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

11.6.5 Everest Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Everest Pharmaceuticals

List of Tables

Table 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Olaparib

Table 3. Key Players of Talazoparib

Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2017-2022)

Table 8. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region (2023-2028)

Table 10. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trends

Table 11. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Drivers

Table 12. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Challenges

Table 13. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Restraints

Table 14. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Players (2017-2022)

Table 16. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2021)

Table 17. Ranking of Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service

Table 21. Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2017-2022)

Table 25. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2023-2028)

Table 27. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Application (2017-2022)

Table 29. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Share by Application (2023-2028)

Table 31. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)

Table 32. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)

Table 33. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)

Table 34. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)

Table 35. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)

Table 36. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)

Table 37. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)

Table 38. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)

Table 39. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)

Table 40. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)

Table 41. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)

Table 42. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)

Table 43. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Region (2023-2028) & (US$ Million)

Table 49. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)

Table 50. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)

Table 51. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)

Table 52. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)

Table 53. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)

Table 54. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2017-2022) & (US$ Million)

Table 56. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2023-2028) & (US$ Million)

Table 57. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2017-2022) & (US$ Million)

Table 58. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2023-2028) & (US$ Million)

Table 59. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2017-2022) & (US$ Million)

Table 60. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Country (2023-2028) & (US$ Million)

Table 61. AbbVie Company Details

Table 62. AbbVie Business Overview

Table 63. AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 64. AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)

Table 65. AbbVie Recent Developments

Table 66. Pfizer Company Details

Table 67. Pfizer Business Overview

Table 68. Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 69. Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)

Table 70. Pfizer Recent Developments

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 74. AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)

Table 75. AstraZeneca Recent Developments

Table 76. GlaxoSmithKline Company Details

Table 77. GlaxoSmithKline Business Overview

Table 78. GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 79. GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)

Table 80. GlaxoSmithKline Recent Developments

Table 81. Clovis Oncology Company Details

Table 82. Clovis Oncology Business Overview

Table 83. Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 84. Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)

Table 85. Clovis Oncology Recent Developments

Table 86. Everest Pharmaceuticals Company Details

Table 87. Everest Pharmaceuticals Business Overview

Table 88. Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Product

Table 89. Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022) & (US$ Million)

Table 90. Everest Pharmaceuticals Recent Developments

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type: 2021 VS 2028

Figure 2. Olaparib Features

Figure 3. Talazoparib Features

Figure 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2021 VS 2028

Figure 5. Ovarian Cancer Case Studies

Figure 6. Breast Cancer Case Studies

Figure 7. Other Case Studies

Figure 8. PARP (Poly ADP-ribose Polymerase) Inhibitors Report Years Considered

Figure 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Region: 2021 VS 2028

Figure 12. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players in 2021

Figure 13. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2021)

Figure 14. The Top 10 and 5 Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2021

Figure 15. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)

Figure 16. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)

Figure 17. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)

Figure 18. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Country (2017-2028)

Figure 19. United States PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Canada PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)

Figure 22. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)

Figure 23. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)

Figure 24. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Country (2017-2028)

Figure 25. Germany PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. France PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. U.K. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Italy PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Russia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Nordic Countries PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Asia-Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)

Figure 32. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)

Figure 33. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)

Figure 34. Asia Pacific PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Region (2017-2028)

Figure 35. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. South Korea PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Australia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 41. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)

Figure 42. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)

Figure 43. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)

Figure 44. Latin America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Country (2017-2028)

Figure 45. Mexico PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 46. Brazil PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Middle East & Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY (2017-2028) & (US$ Million)

Figure 48. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Type (2017-2028)

Figure 49. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Market Share by Application (2017-2028)

Figure 50. Middle East and Africa PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Country (2017-2028)

Figure 51. Turkey PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 52. Saudi Arabia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. UAE PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. AbbVie Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

Figure 55. Pfizer Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

Figure 56. AstraZeneca Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

Figure 57. GlaxoSmithKline Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

Figure 58. Clovis Oncology Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

Figure 59. Everest Pharmaceuticals Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2017-2022)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-19I2859

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions